Potential role of Nigella sativa supplementation with physical activity in prophylaxis and treatment of COVID-19: a contemporary review
- PMID: 34093778
- PMCID: PMC8162633
- DOI: 10.1007/s11332-021-00787-y
Potential role of Nigella sativa supplementation with physical activity in prophylaxis and treatment of COVID-19: a contemporary review
Abstract
The widespread prevalence and mortality of coronavirus diseases-2019 (COVID-19) lead many researchers to study the SARS-CoV-s2 infection to find a treatment for this disease. Discovering the mechanisms of action of COVID-19 and coping at the cellular level with this disease can have better effects. Including the target tissues of this disease are the lungs and the immune system. It is stated that COVID-19 easily infiltrates into alveoli through its receptors and then starts to proliferate. Subsequently, with the weakening of immune cells and increase inflammatory cytokines, it increases the rate of inflammation in the body. Strengthening the immune system and inhibiting COVID-19 receptors can play a preventive or even therapeutic role for this disease. Nigella sativa (N. sativa) is one of the herbal medicines to possess numerous pharmacological effects related to several organs of the body. Among the extraordinary properties of this plant is improving asthma and several lung diseases. The recent studies have shown that N. sativa at the cellular level can inhibit COVID-19 receptors. It was also stated that performing regular exercise training (especially moderate-intensity exercise training) can modulate the immune system and have an anti-inflammatory effect. Since the use of herbal supplements with exercise can have tremendous therapeutic effects at the cellular level, the hypothesis to use the Nigella sativa along with exercise training to prophylaxis and treatment COVID-19 will be highlighted in this paper.
Keywords: COVID-19; Exercise; Nigella sativa supplementation; Physical activity; Prevention; Treatment.
© The Author(s), under exclusive licence to Springer-Verlag Italia S.r.l., part of Springer Nature 2021.
Conflict of interest statement
Conflict of interestThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies.Curr Ther Res Clin Exp. 2020;93:100602. doi: 10.1016/j.curtheres.2020.100602. Epub 2020 Aug 25. Curr Ther Res Clin Exp. 2020. PMID: 32863400 Free PMC article. Review.
-
Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?J Pharmacopuncture. 2020 Jun 30;23(2):62-70. doi: 10.3831/KPI.2020.23.010. J Pharmacopuncture. 2020. PMID: 32685234 Free PMC article. Review.
-
Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review.Int Immunopharmacol. 2015 Sep;28(1):295-304. doi: 10.1016/j.intimp.2015.06.023. Epub 2015 Jun 26. Int Immunopharmacol. 2015. PMID: 26117430 Review.
-
Effect of dexamethasone and Nigella sativa on peripheral blood eosinophil count, IgG1 and IgG2a, cytokine profiles and lung inflammation in murine model of allergic asthma.Egypt J Immunol. 2005;12(1):95-102. Egypt J Immunol. 2005. PMID: 16734144
-
Comparison of Nigella sativa- and exercise-induced models of cardiac hypertrophy: structural and electrophysiological features.Cardiovasc Toxicol. 2014 Sep;14(3):208-13. doi: 10.1007/s12012-014-9244-4. Cardiovasc Toxicol. 2014. PMID: 24448711
Cited by
-
Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects.Inflammopharmacology. 2024 Feb;32(1):273-285. doi: 10.1007/s10787-023-01385-9. Epub 2023 Nov 15. Inflammopharmacology. 2024. PMID: 37966624 Review.
-
Cardiovascular involvement among collegiate athletes following COVID-19 infection.J Clin Transl Res. 2022 Jan 3;8(1):1-5. eCollection 2022 Feb 25. J Clin Transl Res. 2022. PMID: 35097235 Free PMC article.
-
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.Complement Ther Med. 2021 Sep;61:102769. doi: 10.1016/j.ctim.2021.102769. Epub 2021 Aug 15. Complement Ther Med. 2021. PMID: 34407441 Free PMC article. Clinical Trial.
-
The effect of Ni gella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial.Front Pharmacol. 2022 Nov 8;13:1011522. doi: 10.3389/fphar.2022.1011522. eCollection 2022. Front Pharmacol. 2022. PMID: 36425571 Free PMC article.
-
Potential Pharmacological Applications of Nigella Seeds with a Focus on Nigella sativa and Its Constituents against Chronic Inflammatory Diseases: Progress and Future Opportunities.Plants (Basel). 2023 Nov 11;12(22):3829. doi: 10.3390/plants12223829. Plants (Basel). 2023. PMID: 38005726 Free PMC article. Review.
References
-
- Mallapaty S (2020) Scientists fear coronavirus spread in vulnerable nations. Nature 578(7795):348–348 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous